
Panitra 40mg Injection
Marketer
Astrica Biomedics Pvt Ltd
Salt Composition
Pantoprazole (40mg)
Overview Panitra 40mg Injection
Acid reflux, peptic ulcers, and Zollinger-Ellison syndrome are effectively managed by the intravenous Panitra 40mg Injection. This proton pump inhibitor (PPI) decreases stomach acid production, alleviating symptoms and promoting healing. Its use extends to preventing stress ulcers in critically ill patients and pre-anesthesia prophylaxis against aspiration complications. Administered intravenously by a healthcare professional, it's reserved for situations where oral medication is deemed unsuitable. Dosage and treatment duration are determined by your physician based on your individual needs and response. Optimal results are achieved by following your doctor's instructions, even with rapid symptom improvement, and adopting dietary modifications such as smaller, more frequent meals, and avoiding caffeine, spicy, and fatty foods. Common, generally mild side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis. Persistent or bothersome side effects warrant medical attention. Prolonged use, particularly exceeding one year or with high doses, may elevate the risk of bone fractures. Discuss bone health preservation strategies, including calcium and vitamin D supplementation, with your doctor. Panitra 40mg Injection is contraindicated in individuals with severe hepatic impairment, those using HIV medications, those with a history of PPI allergy, or existing osteoporosis. Pregnant or lactating women should seek medical counsel before use. Alcohol consumption should be avoided due to its acid-stimulating properties. Refrain from operating machinery or driving if dizziness or drowsiness occurs.
Primary Ingredients of Panitra 40mg Injection
The provided text is "undefined," therefore no rewriting is possible.
Uses of Panitra 40mg Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Panitra 40mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Panitra 40mg Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Panitra 40mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
How Panitra 40mg Injection works:
Gastric acid secretion is diminished by Panitra 40mg Injection, a proton pump inhibitor, thereby alleviating symptoms of heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption while using Panitra 40mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Panitra 40mg Injection during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Panitra 40mg Injection without significant risk to their infants. Available human data indicates minimal danger to the baby.
DrivingCONSULT YOUR DOCTOR
Panitra 40mg Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Panitra 40mg Injection poses no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
For individuals with severe hepatic impairment, Panitra 40mg Injection requires careful administration. Dosage modification of Panitra 40mg Injection may be necessary. Physician consultation is recommended.
What if you forget to take Panitra 40mg Injection :
Should you forget a scheduled dose of Panitra 40mg Injection, seek advice from your physician.
Facts to Know About Panitra 40mg Injection
| Label | Value |
|---|---|
| Type of Compound | Benzimidazole sulfoxide |
| Potential for Dependence | None. |
| Type of Treatment | Gastrointestinal tract |
| Mechanism of Action | Gastric acid secretion suppressants |
